Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Depression 3Breast Neoplasms 2Anxiety Disorders 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Lymphoma, Follicular 1Lung Neoplasms 1Hospice 1Hematopoietic and Lymphoid System Neoplasm 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Gynecologic Cancer 1Gastrointestinal Neoplasms 1Emotional Regulation 1Colonic Neoplasms 1Advanced Cancer 1Acute Pain 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Psychotherapy × Clear all
NCT06077487 2025-05-21

Ketamine-assisted Therapy for Advanced GI Cancer

University of California, San Francisco

Phase 4 Terminated
1 enrolled 10 charts
Gastrointestinal

Gastrointestinal Neoplasms, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡